MDCE Unveils Multi-Year AI & Healthcare Roadmap, Targets OTCQB Uplisting
MDCE has more than doubled off its 52-week low of $0 on light trading volume (0.1× avg).
Summary
Medical Care Technologies Inc. (MDCE) announced the launch of an updated corporate website, detailing a comprehensive multi-phase strategic roadmap. This roadmap outlines short-term goals including the launch of an upgraded AI mobile application and further asset liquidation (following the recent $200,000 capital generation), near-term goals for 2026 focusing on medical-grade beta applications and AI platform expansion, and long-term goals for 2027 and beyond, including exploring clinical partnerships and pursuing an uplisting to the OTCQB. For an OTC Pink company with a small market cap, this detailed strategic outline provides significant clarity on future product development, capital strategy, and growth initiatives, offering potential catalysts for investors. Traders should monitor progress on AI application launches, medical-grade product development, and any concrete steps towards the OTCQB uplisting.
At the time of this announcement, MDCE was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $663.3K. The 52-week trading range was $0.00 to $0.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.